论文部分内容阅读
最近开展的临床试验证实药物降脂、饮食治疗和改变生活方式可使冠状动脉粥样硬化的发展延迟甚至消退;传统药物的降脂作用较弱,且副作用较大。新问世的 HMG CoA 还原酶抑制剂为药物降脂和使冠状动脉病变消退开辟了前景。
Recent clinical trials confirmed that lipid-lowering drugs, diet therapy and lifestyle changes can delay or even delay the development of coronary atherosclerosis; traditional medicine lipid-lowering effect is weak, and the side effects. The newly emerged HMG CoA reductase inhibitors open up prospects for drug-lowering of lipid and regression of coronary artery disease.